Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Høiby N[au]:

A short history of microbial biofilms and biofilm infections. Høiby N et al. APMIS. (2017)

Mechanisms of humoral immune response against Pseudomonas aeruginosa biofilm infection in cystic fibrosis. Mauch RM et al. J Cyst Fibros. (2018)

The in vivo biofilm. Bjarnsholt T et al. Trends Microbiol. (2013)

Search results

Items: 1 to 50 of 628

1.

Hyperbaric oxygen treatment increases killing of aggregating Pseudomonas aeruginosa isolates from cystic fibrosis patients.

Møller SA, Jensen PØ, Høiby N, Ciofu O, Kragh KN, Bjarnsholt T, Kolpen M.

J Cyst Fibros. 2019 Jan 30. pii: S1569-1993(19)30011-6. doi: 10.1016/j.jcf.2019.01.005. [Epub ahead of print]

PMID:
30711384
2.

Secretory IgA-mediated immune response in saliva and early detection of Pseudomonas aeruginosa in the lower airways of pediatric cystic fibrosis patients.

Mauch RM, Rossi CL, Nolasco da Silva MT, Bianchi Aiello T, Ribeiro JD, Ribeiro AF, Høiby N, Levy CE.

Med Microbiol Immunol. 2019 Jan 31. doi: 10.1007/s00430-019-00578-w. [Epub ahead of print]

PMID:
30706137
3.

Can secretory immunoglobulin A in saliva predict a change in lung infection status in patients with cystic fibrosis? A prospective pilot study.

Alanin MC, Pressler T, Aanaes K, Ekstrøm CT, Skov M, Johansen HK, Nielsen KG, von Buchwald C, Høiby N.

Health Sci Rep. 2018 Jul 12;1(8):e52. doi: 10.1002/hsr2.52. eCollection 2018 Aug.

4.

Formation of Pseudomonas aeruginosa inhibition zone during Tobramycin disk diffusion is due to a transition from planktonic to biofilm mode of growth.

Høiby N, Henneberg KÅ, Wang H, Stavnsbjerg C, Bjarnsholt T, Ciofu O, Johansen UR, Sams T.

Int J Antimicrob Agents. 2019 Jan 4. pii: S0924-8579(18)30385-6. doi: 10.1016/j.ijantimicag.2018.12.015. [Epub ahead of print]

5.

Antibody response against Mycobacterium avium complex in cystic fibrosis patients measured by a novel IgG ELISA test.

Ravnholt C, Qvist T, Kolpen M, Pressler T, Skov M, Høiby N.

J Cyst Fibros. 2018 Nov 29. pii: S1569-1993(18)30938-X. doi: 10.1016/j.jcf.2018.11.011. [Epub ahead of print]

PMID:
30503330
6.

Adaptation of Pseudomonas aeruginosa to the chronic phenotype by mutations in the algTmucABD operon in isolates from Brazilian cystic fibrosis patients.

Candido Caçador N, Paulino da Costa Capizzani C, Gomes Monteiro Marin Torres LA, Galetti R, Ciofu O, da Costa Darini AL, Høiby N.

PLoS One. 2018 Nov 29;13(11):e0208013. doi: 10.1371/journal.pone.0208013. eCollection 2018.

7.

The importance of early diagnosis of Mycobacterium abscessus complex in patients with cystic fibrosis.

Ravnholt C, Kolpen M, Skov M, Moser C, Katzenstein TL, Pressler T, Høiby N, Qvist T.

APMIS. 2018 Dec;126(12):885-891. doi: 10.1111/apm.12903. Review.

PMID:
30456869
8.

Next generation microbiology and cystic fibrosis diagnostics: are we there yet?

Moser C, Thomsen TR, Høiby N.

Curr Opin Pulm Med. 2018 Nov;24(6):599-605. doi: 10.1097/MCP.0000000000000516.

PMID:
30074508
9.

Erratum: Chronic Pseudomonas aeruginosa biofilm infection impairs murine S100A8/A9 and neutrophil effector cytokines-implications for delayed wound closure?

Trøstrup H, Lerche CJ, Christophersen LJ, Thomsen K, Jensen PØ, Hougen HP, Høiby N, Moser C.

Pathog Dis. 2017 Nov 30;75(8). doi: 10.1093/femspd/ftx110. No abstract available.

PMID:
30052962
10.

Modelling of ciprofloxacin killing enhanced by hyperbaric oxygen treatment in Pseudomonas aeruginosa PAO1 biofilms.

Gade PAV, Olsen TB, Jensen PØ, Kolpen M, Høiby N, Henneberg KÅ, Sams T.

PLoS One. 2018 Jun 14;13(6):e0198909. doi: 10.1371/journal.pone.0198909. eCollection 2018.

11.

Evolution of Antibiotic Resistance in Biofilm and Planktonic Pseudomonas aeruginosa Populations Exposed to Subinhibitory Levels of Ciprofloxacin.

Ahmed MN, Porse A, Sommer MOA, Høiby N, Ciofu O.

Antimicrob Agents Chemother. 2018 Jul 27;62(8). pii: e00320-18. doi: 10.1128/AAC.00320-18. Print 2018 Aug.

12.

A systematic review of studies on the faecal microbiota in anorexia nervosa: future research may need to include microbiota from the small intestine.

Schwensen HF, Kan C, Treasure J, Høiby N, Sjögren M.

Eat Weight Disord. 2018 Aug;23(4):399-418. doi: 10.1007/s40519-018-0499-9. Epub 2018 Mar 14. Review.

PMID:
29542066
13.

The accessibility of topical treatment in the paranasal sinuses on operated cystic fibrosis patients assessed by scintigraphy.

Aanaes K, Alanin MC, Nielsen KG, Moller Jorgensen M, von Buchwald C, Hoiby N, Johansen HK, Johannesen HH, Mortensen J.

Rhinology. 2018 Sep 1;56(3):268-273. doi: 10.4193/Rhin17.243.

PMID:
29509830
14.

Pseudomonas aeruginosa biofilm hampers murine central wound healing by suppression of vascular epithelial growth factor.

Trøstrup H, Lerche CJ, Christophersen LJ, Thomsen K, Jensen PØ, Hougen HP, Høiby N, Moser C.

Int Wound J. 2018 Feb;15(1):123-132. doi: 10.1111/iwj.12846. Epub 2017 Nov 27.

PMID:
29178668
15.

Mechanisms of humoral immune response against Pseudomonas aeruginosa biofilm infection in cystic fibrosis.

Mauch RM, Jensen PØ, Moser C, Levy CE, Høiby N.

J Cyst Fibros. 2018 Mar;17(2):143-152. doi: 10.1016/j.jcf.2017.08.012. Epub 2017 Oct 21. Review.

PMID:
29033275
16.

IgG avidity to Pseudomonas aeruginosa over the course of chronic lung biofilm infection in cystic fibrosis.

Mauch RM, Nørregaard LL, Ciofu O, Levy CE, Høiby N.

J Cyst Fibros. 2018 May;17(3):356-359. doi: 10.1016/j.jcf.2017.09.004. Epub 2017 Oct 12.

PMID:
29032178
17.

Hyperbaric Oxygen Sensitizes Anoxic Pseudomonas aeruginosa Biofilm to Ciprofloxacin.

Kolpen M, Lerche CJ, Kragh KN, Sams T, Koren K, Jensen AS, Line L, Bjarnsholt T, Ciofu O, Moser C, Kühl M, Høiby N, Jensen PØ.

Antimicrob Agents Chemother. 2017 Oct 24;61(11). pii: e01024-17. doi: 10.1128/AAC.01024-17. Print 2017 Nov.

18.

Sinus bacteriology in patients with cystic fibrosis or primary ciliary dyskinesia: A systematic review.

Møller ME, Alanin MC, Grønhøj C, Aanæs K, Høiby N, von Buchwald C.

Am J Rhinol Allergy. 2017 Sep 1;31(5):293-298. doi: 10.2500/ajra.2017.31.4461. Review.

19.

Immune Modulating Topical S100A8/A9 Inhibits Growth of Pseudomonas aeruginosa and Mitigates Biofilm Infection in Chronic Wounds.

Trøstrup H, Lerche CJ, Christophersen L, Jensen PØ, Høiby N, Moser C.

Int J Mol Sci. 2017 Jun 26;18(7). pii: E1359. doi: 10.3390/ijms18071359.

20.

Hyperbaric oxygen therapy augments tobramycin efficacy in experimental Staphylococcus aureus endocarditis.

Lerche CJ, Christophersen LJ, Kolpen M, Nielsen PR, Trøstrup H, Thomsen K, Hyldegaard O, Bundgaard H, Jensen PØ, Høiby N, Moser C.

Int J Antimicrob Agents. 2017 Sep;50(3):406-412. doi: 10.1016/j.ijantimicag.2017.04.025. Epub 2017 Jun 29.

PMID:
28669832
21.

Chronic Pseudomonas aeruginosa biofilm infection impairs murine S100A8/A9 and neutrophil effector cytokines-implications for delayed wound closure?

Trøstrup H, Lerche CJ, Christophersen LJ, Thomsen K, Jensen PØ, Hougen HP, Høiby N, Moser C.

Pathog Dis. 2017 Sep 29;75(7). doi: 10.1093/femspd/ftx068. Erratum in: Pathog Dis. 2017 Nov 30;75(8):.

PMID:
28645160
22.

Secretory IgA response against Pseudomonas aeruginosa in the upper airways and the link with chronic lung infection in cystic fibrosis.

Mauch RM, Rossi CL, Aiello TB, Ribeiro JD, Ribeiro AF, Høiby N, Levy CE.

Pathog Dis. 2017 Aug 31;75(6). doi: 10.1093/femspd/ftx069.

PMID:
28645157
23.

Mouse Model of Burn Wound and Infection: Thermal (Hot Air) Lesion-Induced Immunosuppression.

Calum H, Høiby N, Moser C.

Curr Protoc Mouse Biol. 2017 Jun 19;7(2):77-87. doi: 10.1002/cpmo.25.

PMID:
28628217
24.

Diagnosis of biofilm infections in cystic fibrosis patients.

Høiby N, Bjarnsholt T, Moser C, Jensen PØ, Kolpen M, Qvist T, Aanaes K, Pressler T, Skov M, Ciofu O.

APMIS. 2017 Apr;125(4):339-343. doi: 10.1111/apm.12689. Review.

PMID:
28407432
25.

Chronic urinary tract infections in patients with spinal cord lesions - biofilm infection with need for long-term antibiotic treatment.

Tofte N, Nielsen AC, Trøstrup H, Andersen CB, Von Linstow M, Hansen B, Biering-Sørensen F, Høiby N, Moser C.

APMIS. 2017 Apr;125(4):385-391. doi: 10.1111/apm.12685. Review.

PMID:
28407430
26.

Biofilms and host response - helpful or harmful.

Moser C, Pedersen HT, Lerche CJ, Kolpen M, Line L, Thomsen K, Høiby N, Jensen PØ.

APMIS. 2017 Apr;125(4):320-338. doi: 10.1111/apm.12674. Review.

PMID:
28407429
27.

A short history of microbial biofilms and biofilm infections.

Høiby N.

APMIS. 2017 Apr;125(4):272-275. doi: 10.1111/apm.12686. Review.

PMID:
28407426
28.

Experimental Pseudomonas aeruginosa mediated rhino sinusitis in mink.

Kirkeby S, Hammer AS, Høiby N, Salomonsen CM.

Int J Pediatr Otorhinolaryngol. 2017 May;96:156-163. doi: 10.1016/j.ijporl.2016.12.037. Epub 2016 Dec 27.

PMID:
28302328
29.

Individual pharmacokinetic variation leads to underdosing of ciprofloxacin in some cystic fibrosis patients.

Schultz AN, Høiby N, Nielsen XC, Pressler T, Dalhoff K, Duno M, Buchard A, Johansen HK, Wang H, Dalbøge CS.

Pediatr Pulmonol. 2017 Mar;52(3):319-323. doi: 10.1002/ppul.23638. Epub 2016 Nov 4.

PMID:
28221736
30.

Sinus surgery can improve quality of life, lung infections, and lung function in patients with primary ciliary dyskinesia.

Alanin MC, Aanaes K, Høiby N, Pressler T, Skov M, Nielsen KG, Johansen HK, von Buchwald C.

Int Forum Allergy Rhinol. 2017 Mar;7(3):240-247. doi: 10.1002/alr.21873. Epub 2016 Nov 23.

PMID:
27879058
31.

Phenotypic shift in Pseudomonas aeruginosa populations from cystic fibrosis lungs after 2-week antipseudomonal treatment.

Fernández-Barat L, Ciofu O, Kragh KN, Pressler T, Johansen U, Motos A, Torres A, Hoiby N.

J Cyst Fibros. 2017 Mar;16(2):222-229. doi: 10.1016/j.jcf.2016.08.005. Epub 2016 Sep 17.

PMID:
27651273
32.

Evaluation of a bovine antibody test for diagnosing Mycobacterium avium complex in patients with cystic fibrosis.

Qvist T, Pressler T, Katzenstein TL, Høiby N, Collins MT.

Pediatr Pulmonol. 2017 Jan;52(1):34-40. doi: 10.1002/ppul.23608. Epub 2016 Sep 20.

PMID:
27648735
33.

The dlt genes play a role in antimicrobial tolerance of Streptococcus mutans biofilms.

Nilsson M, Rybtke M, Givskov M, Høiby N, Twetman S, Tolker-Nielsen T.

Int J Antimicrob Agents. 2016 Sep;48(3):298-304. doi: 10.1016/j.ijantimicag.2016.06.019. Epub 2016 Jul 28.

PMID:
27502751
34.

Bacterial evolution in PCD and CF patients follows the same mutational steps.

Sommer LM, Alanin MC, Marvig RL, Nielsen KG, Høiby N, von Buchwald C, Molin S, Johansen HK.

Sci Rep. 2016 Jun 28;6:28732. doi: 10.1038/srep28732.

35.

Sinus surgery postpones chronic Gram-negative lung infection: cohort study of 106 patients with cystic fibrosis.

Alanin MC, Aanaes K, Høiby N, Pressler T, Skov M, Nielsen KG, Taylor-Robinson D, Waldmann E, Krogh Johansen H, von Buchwald C.

Rhinology. 2016 Sep;54(3):206-13. doi: 10.4193/Rhin15.347.

PMID:
27116399
36.

Diffusion Retardation by Binding of Tobramycin in an Alginate Biofilm Model.

Cao B, Christophersen L, Kolpen M, Jensen PØ, Sneppen K, Høiby N, Moser C, Sams T.

PLoS One. 2016 Apr 21;11(4):e0153616. doi: 10.1371/journal.pone.0153616. eCollection 2016.

37.

S100A8/A9 is an important host defence mediator in neuropathic foot ulcers in patients with type 2 diabetes mellitus.

Trøstrup H, Holstein P, Christophersen L, Jørgensen B, Karlsmark T, Høiby N, Moser C, Ågren MS.

Arch Dermatol Res. 2016 Jul;308(5):347-55. doi: 10.1007/s00403-016-1646-7. Epub 2016 Apr 15.

PMID:
27084691
38.

[Augmented renal clearance of antibiotics may lead to inadequate dosings for patients with sepsis].

Moser C, Hartvig T, Schierbeck J, Høiby N.

Ugeskr Laeger. 2016 Mar 14;178(11):V05150426. Review. Danish.

PMID:
27032308
39.

Activation of pulmonary and lymph node dendritic cells during chronic Pseudomonas aeruginosa lung infection in mice.

Damlund DS, Christophersen L, Jensen PØ, Alhede M, Høiby N, Moser C.

APMIS. 2016 Jun;124(6):500-7. doi: 10.1111/apm.12530. Epub 2016 Mar 24.

PMID:
27009697
40.

The phenotypic evolution of Pseudomonas aeruginosa populations changes in the presence of subinhibitory concentrations of ciprofloxacin.

Wassermann T, Meinike Jørgensen K, Ivanyshyn K, Bjarnsholt T, Khademi SM, Jelsbak L, Høiby N, Ciofu O.

Microbiology. 2016 May;162(5):865-75. doi: 10.1099/mic.0.000273. Epub 2016 Mar 7.

PMID:
26953154
41.

Genome Sequence of Pseudomonas aeruginosa Strain DK1-NH57388A, a Stable Mucoid Cystic Fibrosis Isolate.

Norman A, Ciofu O, Amador CI, Høiby N, Jelsbak L.

Genome Announc. 2016 Feb 25;4(1). pii: e00008-16. doi: 10.1128/genomeA.00008-16.

42.

Anti-Pseudomonas aeruginosa IgY antibodies promote bacterial opsonization and augment the phagocytic activity of polymorphonuclear neutrophils.

Thomsen K, Christophersen L, Jensen PØ, Bjarnsholt T, Moser C, Høiby N.

Hum Vaccin Immunother. 2016 Jul 2;12(7):1690-9. doi: 10.1080/21645515.2016.1145848. Epub 2016 Feb 22.

43.

OligoG CF-5/20 Disruption of Mucoid Pseudomonas aeruginosa Biofilm in a Murine Lung Infection Model.

Hengzhuang W, Song Z, Ciofu O, Onsøyen E, Rye PD, Høiby N.

Antimicrob Agents Chemother. 2016 Apr 22;60(5):2620-6. doi: 10.1128/AAC.01721-15. Print 2016 May.

44.

The phagocytic fitness of leucopatches may impact the healing of chronic wounds.

Thomsen K, Trøstrup H, Christophersen L, Lundquist R, Høiby N, Moser C.

Clin Exp Immunol. 2016 Jun;184(3):368-77. doi: 10.1111/cei.12773. Epub 2016 Mar 23.

45.

Reinforcement of the bactericidal effect of ciprofloxacin on Pseudomonas aeruginosa biofilm by hyperbaric oxygen treatment.

Kolpen M, Mousavi N, Sams T, Bjarnsholt T, Ciofu O, Moser C, Kühl M, Høiby N, Jensen PØ.

Int J Antimicrob Agents. 2016 Feb;47(2):163-7. doi: 10.1016/j.ijantimicag.2015.12.005. Epub 2015 Dec 29.

PMID:
26774522
46.

New technology markedly improves hand-hygiene performance among healthcare workers after restroom visits.

Møller-Sørensen H, Korshin A, Mogensen T, Høiby N.

J Hosp Infect. 2016 Apr;92(4):337-9. doi: 10.1016/j.jhin.2015.09.012. Epub 2015 Oct 22.

PMID:
26597634
47.

Chronic pulmonary disease with Mycobacterium abscessus complex is a biofilm infection.

Qvist T, Eickhardt S, Kragh KN, Andersen CB, Iversen M, Høiby N, Bjarnsholt T.

Eur Respir J. 2015 Dec;46(6):1823-6. doi: 10.1183/13993003.01102-2015. Epub 2015 Oct 22. No abstract available.

48.

Comparing the harmful effects of nontuberculous mycobacteria and Gram negative bacteria on lung function in patients with cystic fibrosis.

Qvist T, Taylor-Robinson D, Waldmann E, Olesen HV, Hansen CR, Mathiesen IH, Høiby N, Katzenstein TL, Smyth RL, Diggle PJ, Pressler T.

J Cyst Fibros. 2016 May;15(3):380-5. doi: 10.1016/j.jcf.2015.09.007. Epub 2015 Oct 9.

49.

The LapG protein plays a role in Pseudomonas aeruginosa biofilm formation by controlling the presence of the CdrA adhesin on the cell surface.

Rybtke M, Berthelsen J, Yang L, Høiby N, Givskov M, Tolker-Nielsen T.

Microbiologyopen. 2015 Dec;4(6):917-30. doi: 10.1002/mbo3.301. Epub 2015 Oct 12.

50.

Increased bactericidal activity of colistin on Pseudomonas aeruginosa biofilms in anaerobic conditions.

Kolpen M, Appeldorff CF, Brandt S, Mousavi N, Kragh KN, Aydogan S, Uppal HA, Bjarnsholt T, Ciofu O, Høiby N, Jensen PØ.

Pathog Dis. 2016 Feb;74(1):ftv086. doi: 10.1093/femspd/ftv086. Epub 2015 Oct 12.

Supplemental Content

Support Center